Graybug
is a California-based clinical stage biopharmaceutical company that develops drug delivery therapies for chronic vision-threatening eye diseases... Read moreGraybug
is a California-based clinical stage biopharmaceutical company that develops drug delivery therapies for chronic vision-threatening eye diseases... Read more
2011
PrivateMerged with CalciMedica Inc
News
Mar 20, 2023
BioSpace
Graybug: CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
Mar 20, 2023
MarketScreener
Graybug: Graybug Announces Name and Trading Symbol Change
Feb 16, 2023
MarketScreener
Graybug: Graybug Vision : NOTE PURCHASE AGREEMENT - Form 8-K
Feb 14, 2023
MarketScreener
Graybug: GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY
Dec 21, 2022
PR-Inside
Press Release: Graybug : SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJRD, GRAY, ...
Dec 06, 2022
NewsFile
Press Release: Graybug : SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graybug Vision, Inc. (GRAY)
Dec 01, 2022
GlobalNewswire
Press Release: Graybug : Lifshitz Law PLLC Announces Investigations of APEN, GRAY, RBA, and PEBO
Nov 26, 2022
Global Legal Chronicle
Graybug: CalciMedica's $35 Million Merger with Graybug
Nov 24, 2022
Life Care News
Graybug: GRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAY
Nov 24, 2022
Medthority
Graybug: Graybug Vision and CalciMedica to merge and focus on the development of Auxora.